Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
Medical Xpress: A Lesser-Known SARS-CoV-2 Protein May Offer Clues To Long COVID Symptoms
A new UCLA study published in Science Advances describes a previously unrecognized way the SARS-CoV-2 nucleocapsid protein can push the immune system into dangerous overdrive. (8/5)
HealthDay: Bacterial Vaginosis Tied To Triple STI Risk, Major Study Finds
Women with vaginosis are around three times as likely to also test positive for gonorrhea, chlamydia or other bacterial sexually transmitted infections, a new study says. (Thompson, 8/4)
HealthDay: High Body Fat, Not BMI, Tied To Lower Sperm Counts In Men
A higher body fat percentage is linked to lower sperm counts and changes in the balance of testosterone and other male hormones, researchers reported July 29 in the journal Human Reproduction. (Thompson, 8/4)
MedPage Today: Bone Density Appears To Rebound In Transgender Youth After Puberty Blockers Are Done
Bone growth among transgender and gender-diverse adolescents slowed compared with peers during pubertal suppression, but partially recovered after starting gender-affirming hormone therapy, a systematic review and meta-analysis showed. (Monaco, 8/3)
Stat: Novo Nordisk Anti-Inflammation Drug Misses In Heart Disease Study
Novo Nordisk said Friday that its investigational anti-inflammatory drug did not reduce the risk of major heart events in a pivotal trial, raising questions about the increasingly popular approach of targeting inflammation to prevent cardiovascular complications. (Chen, 7/31)
MedPage Today: Use Of PDE5 Inhibitor Tied To Increased Glaucoma Risk
Men who used the PDE5 inhibitor tadalafil (Cialis) for lower urinary tract symptoms had an increased likelihood of developing glaucoma-related clinical events, according to a large retrospective study. (Bankhead, 8/5)
MedPage Today: Study Examines Link Between IBD And Psychiatric Disorders
Patients with inflammatory bowel disease were at increased risk for several psychiatric disorders both before and after diagnosis, according to results from a Swedish cohort study. (Bassett, 8/5)
Stat: Could Poop Pills Be The Next Treatment For Food Allergies?
In an early-stage clinical trial, six participants with peanut allergy showed improved tolerance to small peanut exposures up to four months after they received fecal microbiome transplant using stool capsules. (Chan, 8/5)
